Topical Aminoglycoside — Otitis Externa
Pregnancy: Avoid if possible — aminoglycoside ototoxicity risk; topical use with intact TM has minimal systemic absorption
Gentamicin Ear Drops
Brand names: Genticin Ear Drops, Cidomycin
Adult dose
Dose: 2–4 drops
Route: Otic
Frequency: Three to four times daily
Max: 4 drops per ear four times daily
Topical aminoglycoside antibiotic for chronic suppurative otitis media (CSOM) and otitis externa. CONTRAINDICATED with tympanic membrane perforation — risk of sensorineural hearing loss (cochlear toxicity via round window absorption).
Paediatric dose
Dose: 2–3 drops drops/kg
Route: Otic
Frequency: Three times daily
Max: 3 drops per ear three times daily
BNFc: use only under specialist supervision in children with intact tympanic membrane. AVOID in perforation — ototoxicity risk.
Dose adjustments
Renal
No systemic dose adjustment required (topical); however, systemic absorption can occur with perforated TM — avoid in renal impairment with perforated TM
Hepatic
No dose adjustment required
Paediatric weight-based calculator
BNFc: use only under specialist supervision in children with intact tympanic membrane. AVOID in perforation — ototoxicity risk.
Clinical pearls
- CONTRAINDICATED with tympanic membrane perforation — aminoglycosides absorbed via round window → cochlear hair cell death → permanent sensorineural hearing loss
- CSOM with perforation: use topical quinolone (ciprofloxacin ear drops/Ciloxan) which is safe with perforation — preferred by NICE and ENT-UK
- Genticin (gentamicin 0.3%) available alone or combined with hydrocortisone (Gentisone HC) for combined antibacterial and anti-inflammatory action
- Annual audiology recommended for patients on long-term topical aminoglycosides
- Middle ear irrigation with gentamicin solution (intratympanic gentamicin) is used therapeutically for Menière's disease — chemical labyrinthectomy to ablate vestibular function; deliberate vestibulotoxicity
Contraindications
- Perforated tympanic membrane — CONTRAINDICATED (ototoxicity)
- Aminoglycoside hypersensitivity
Side effects
- Sensorineural hearing loss (permanent — with perforated TM)
- Vestibular toxicity
- Local irritation
Interactions
- Systemic aminoglycosides — additive ototoxicity risk
Monitoring
- Audiometry (if prolonged use)
- Symptom response
- Tympanic membrane integrity before prescribing
Reference: BNFc; BNF 90; BNFc; NICE CKS Otitis Externa; ENT-UK CSOM Guidelines; BSO Menière's Disease Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020